USPTO serial 78227284
PRODUCELL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BRECKENFELD, WILLIAM G
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PRODUCELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Leuven, Vlaams-Brabant, BE
Leuven, Vlaams-Brabant, BE
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, biological and biotechnological preparations and substances for scientific and medical research use, namely, recombinant vectors for cloning; proteins and reagents for scientific and medical research use, namely, for use in recombinant protein expression purification; manipulating and expressing recombinant DNA for industrial, scientific, and medical research use; chemical, biochemical, biological and biotechnological preparations and substances, namely, recombinant vectors for industrial, scientific, and medical research use in laboratories, diagnostics and analytics; chemical, biochemical, biological and biotechnological preparations and substances, namely, cell growth support structures and substrates for use in cell cultures for industrial, scientific and medical research; chemical, biochemical, biological and biotechnological preparations and substances for use in the manufacture of medicines, pharmaceuticals, diagnostics, vaccines, antibodies and biological molecules; synthetic resins, preparations and substances for use in the manufacture of medicines, pharmaceuticals, diagnostics, vaccines, antibodies and biological molecules; and auxiliary preparations, carriers and substances for use in the manufacture of medicines, pharmaceuticals, diagnostics, vaccines, antibodies and biological molecules | ACTIVE | — |
| 005 | Pre-mixed, pre-dispensed reagents, namely, nucleotides and nucleotide preparations, ionic salts, buffer, and stabilizing reagents, or a combination thereof, for performing, polymerase chain reaction, DNA profiling experiments and random amplified polymorphic DNA analysis detection, labeling and or sequencing of DNA; pre-mixed, pre-dispensed reagents, namely, a lambda packaging kit primarily comprised of nucleotides and nucleotide preparations for in vitro packaging and planting of CDNA and biochemicals, namely, sets of cloned DNA fragments that together represent the entire genome, to the genes transcribed by a particular tissue cloned into bacteriophage lambda DNA; pre-mixed, pre-dispensed reagents, namely, vectors for the general cloning, sequencing and expression of foreign genes; pre-mixed, pre-dispensed reagents, namely, polynucleotide kinase for use in the detection labeling and or sequencing of DNA or RNA and chemical reagents for use therewith; and pre-mixed, pre-dispensed reagents, namely, DNA ligase for covalently joining DNA fragments; all for medical or clinical laboratory use; manipulating and expressing recombinant DNA for medical use; chemical, biochemical, biological and biotechnological preparations and substances, namely, recombinant vectors for medical use in laboratories, diagnostics and analytics | ACTIVE | — |
| 040 | Custom manufacture of reagents for others, namely, customized synthesis of biological matter | ACTIVE | — |
| 042 | Provision of molecular biology services, namely, recombinant DNA cloning, nucleic acid isolation and analysis, and consultation services for design and execution of molecular biology experiments; medical and scientific research and product development services for others; chemical analysis in the field of biochemistry; laboratory research in the field of biotechnology; conducting screening assays for drug development; biological cloning services; chemical analysis; diagnostic services in the field of recombinant production; development of new technology for the others in the field of recombinant biotechnology; product research and development, scientific research; technical consultation in the field of biotechnology; product research and development; scientific research; technical consultation in the field of biotechnology and in the field of recombinant production technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Thromb-X nv
- Other trademarks owned by Thromb-X nv
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PRODUCELL
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 10, 2007 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 6, 2007 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 26, 2006 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 1, 2006 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Mar 8, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 20, 2004 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 27, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 7, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 1, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2003 | EMRV | EMAIL RECEIVED | — |
| Oct 31, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2003 | DOCK | ASSIGNED TO EXAMINER | — |